A phase I study of GKT-771

Trial Profile

A phase I study of GKT-771

Phase of Trial: Phase I

Latest Information Update: 27 Jul 2017

At a glance

  • Drugs GKT 771 (Primary)
  • Indications Cancer; Inflammation; Pain
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Jul 2017 According to a GenKyoTex media release, this study is anticipated to start at the end of 2017.
    • 02 Jan 2017 New trial record
    • 22 Dec 2016 According to a GENTICEL, media release, the company expects to initiate this study in the second half of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top